The impact of dapagliflozin on cardiovascular system in the course of type 2 diabetes mellitus

Stelmaszyk, Agnieszka; Dworacka, Marzena

doi:10.5603/dk.2017.0024

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other drugs that might be beneficial are sodium-glucose cotransporter 2 (SGLT2) inhibitors due to their additional diuretic effect in patients with volume overload induced by parenteral nutrition. Currently, SGLT2 inhibitors may also be used in patients with diabetes type 1 in some clinical settings, and even in patients with heart failure without concomitant diabetes [13,14]. For these reasons, a proper diagnosis of diabetes is the basis for selecting appropriate treatment in patients after intestinal resection.…”

Section: Discussionmentioning

confidence: 99%

Pacjent żywiony parenteralnie – problem z insulinoterapią i nie tylko.

Kleibert

Mrozikiewicz-Rakowska

Czupryniak

2021

Clinical Diabetology

View full text Add to dashboard Cite

the management of diabetic patients after resection of large intestinal sections is a significant clinical problem, particularly when parenteral nutrition is required, which increases the risk of hyperglycaemia. On the example of a patient who underwent subtotal resection of the small intestine due to mesenteric artery embolism, possible approaches to blood glucose lowering treatment in such patients in the perioperative period were discussed. We presented the current perspective on insulin therapy during parenteral nutrition and proposed a regimen for such treatment. Potential use of glucagon-like peptide 2 analogues in patients with short bowel syndrome was also highlighted. (clin Diabetol 2021; 10)

show abstract

Section: Discussionmentioning

confidence: 99%